{"entity":{"id":"radiopharmacy-network","kind":"technology","name":"Radiopharmacy and cyclotron networks","aka":[],"tldr":"The factories and courier routes that make and deliver short-lived radioactive tracers to hospitals within hours.","summary":"PET tracers (18F, half-life 110 minutes) are produced in regional cyclotron pharmacies and driven or flown to scanners the same day; 68Ga comes from generators or cyclotrons on site; 177Lu and 225Ac therapies are made centrally and shipped globally against decay. Networks: PETNET (Siemens), Cardinal Health, SOFIE, Curium, Jubilant Radiopharma, Isologic/Isorad in Canada, with regional players in Europe and Asia. Capacity and licensing of nuclear pharmacies limits where radioligand therapy can be given.","status":"standard-of-care","asOf":"2026-09-08","links":[{"label":"21 CFR Part 212: current good manufacturing practice for PET drugs","url":"https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-212"}],"tags":["supporting"],"related":["f-18","ga-68","lu-177","ac-225"],"indications":[],"sections":[],"technologies":["pet","psma-pet","radioligand-therapy","therapy-isotope-supply-chain"],"targets":[],"drugs":[],"companies":["petnet-solutions","cardinal-health","sofie-biosciences","curium","jubilant-radiopharma"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":["medical-cyclotrons-synthesis-modules"],"notes":[],"principle":"Cyclotron proton bombardment or generator elution produces the isotope; automated synthesis modules label the ligand; QC release within an hour; timed logistics deliver a calibrated activity.","strengths":["Same-day supply of 18F tracers across most high-income regions","Established GMP frameworks"],"limitations":["Rural and low-income coverage gaps","Therapy isotope logistics against decay","Single points of failure in reactor supply"]},"route":"/technologies/radiopharmacy-network/","neighbours":{"isotope":[{"id":"ac-225","kind":"isotope","name":"Actinium-225","route":"/isotopes/ac-225/"},{"id":"f-18","kind":"isotope","name":"Fluorine-18","route":"/isotopes/f-18/"},{"id":"ga-68","kind":"isotope","name":"Gallium-68","route":"/isotopes/ga-68/"},{"id":"lu-177","kind":"isotope","name":"Lutetium-177","route":"/isotopes/lu-177/"}],"technology":[{"id":"cyclotron-isotope-production","kind":"technology","name":"Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)","route":"/technologies/cyclotron-isotope-production/"},{"id":"dota-chelation","kind":"technology","name":"DOTA chelation","route":"/technologies/dota-chelation/"},{"id":"gamma-probes-dose-calibrators","kind":"technology","name":"Gamma probes, handheld gamma cameras and dose calibrators","route":"/technologies/gamma-probes-dose-calibrators/"},{"id":"medical-cyclotrons-synthesis-modules","kind":"technology","name":"Medical cyclotrons, hot cells, and synthesis modules","route":"/technologies/medical-cyclotrons-synthesis-modules/"},{"id":"pet","kind":"technology","name":"PET (positron emission tomography)","route":"/technologies/pet/"},{"id":"pet-tracer-manufacturing","kind":"technology","name":"PET tracer manufacturing and distribution","route":"/technologies/pet-tracer-manufacturing/"},{"id":"psma-pet","kind":"technology","name":"PSMA PET","route":"/technologies/psma-pet/"},{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"},{"id":"radiopharmaceutical-gmp-release","kind":"technology","name":"Radiopharmaceutical GMP and releasing a drug that decays","route":"/technologies/radiopharmaceutical-gmp-release/"},{"id":"research-reactor-isotope-production","kind":"technology","name":"Research reactors for medical isotopes (Mo-99, Lu-177, I-131)","route":"/technologies/research-reactor-isotope-production/"},{"id":"targeted-alpha-therapy","kind":"technology","name":"Targeted alpha therapy","route":"/technologies/targeted-alpha-therapy/"},{"id":"therapy-isotope-supply-chain","kind":"technology","name":"Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)","route":"/technologies/therapy-isotope-supply-chain/"}],"company":[{"id":"ansto","kind":"company","name":"ANSTO (Australian Nuclear Science and Technology Organisation)","route":"/companies/ansto/"},{"id":"cardinal-health","kind":"company","name":"Cardinal Health Nuclear & Precision Health Solutions","route":"/companies/cardinal-health/"},{"id":"curium","kind":"company","name":"Curium","route":"/companies/curium/"},{"id":"eckert-ziegler","kind":"company","name":"Eckert & Ziegler","route":"/companies/eckert-ziegler/"},{"id":"jubilant-radiopharma","kind":"company","name":"Jubilant Radiopharma","route":"/companies/jubilant-radiopharma/"},{"id":"petnet-solutions","kind":"company","name":"PETNET Solutions (Siemens Healthineers)","route":"/companies/petnet-solutions/"},{"id":"sofie-biosciences","kind":"company","name":"SOFIE Biosciences","route":"/companies/sofie-biosciences/"}],"bottleneck":[{"id":"b-cold-chain-logistics","kind":"bottleneck","name":"Cold chain and time-critical logistics","route":"/bottlenecks/b-cold-chain-logistics/"},{"id":"b-hot-lab-capacity","kind":"bottleneck","name":"Hot lab and shielded treatment room capacity","route":"/bottlenecks/b-hot-lab-capacity/"},{"id":"b-nuclear-medicine-workforce","kind":"bottleneck","name":"Nuclear medicine technologist and physicist workforce","route":"/bottlenecks/b-nuclear-medicine-workforce/"},{"id":"b-radioactive-waste-regulation","kind":"bottleneck","name":"Radioactive waste handling and disposal regulation","route":"/bottlenecks/b-radioactive-waste-regulation/"},{"id":"b-reimbursement-coding","kind":"bottleneck","name":"Reimbursement and coding for radiopharmaceuticals","route":"/bottlenecks/b-reimbursement-coding/"},{"id":"b-site-readiness-referral","kind":"bottleneck","name":"Site readiness and referral pathway delays","route":"/bottlenecks/b-site-readiness-referral/"}],"section":[{"id":"f-isotope-supply","kind":"section","name":"Isotope supply","route":"/fronts/f-isotope-supply/"}],"idea":[{"id":"idea-regional-radiopharmacy-network","kind":"idea","name":"In-house hospital radiopharmacy compounding to cut dose waste","route":"/ideas/idea-regional-radiopharmacy-network/"}],"paper":[{"id":"paper-herrmann-radiotheranostics-lancet-oncol-2020","kind":"paper","name":"Radiotheranostics: a roadmap for future development","route":"/key-papers/paper-herrmann-radiotheranostics-lancet-oncol-2020/"}],"roadmap":[{"id":"isotope-supply-roadmap","kind":"roadmap","name":"Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium","route":"/roadmaps/isotope-supply-roadmap/"}],"term":[{"id":"radiopharmacy-term","kind":"term","name":"Radiopharmacy (practice and discipline)","route":"/terms/radiopharmacy-term/"}]}}